Skip to main content
. 2018 Oct 30;6(1):33–45. doi: 10.1002/acn3.676

Table 1.

Demographic characteristics of study population

Healthy controls (n = 18) Multiple sclerosis (n = 18)
Age (years), mean(SD) 43.9 (10.8) 41.3 (10.0)
Female sex, n(%) 13 (72.2) 13 (72.2)
Race
Caucasian 16 16
African American 2 2
Disease duration (years), mean(SD) 9.8 (6.2)
EDSS, median (IQR) 2 (1.5)
Previous treatment
None 6
Glatiramer 5
Interferon beta 5
Natalizumab 2
Lymphopenia
None 10
Grade 1 2
Grade 2 5
Grade 3 1